Completed PHASE4 INTERVENTIONAL 2-arm NCT00829322

Modafinil for the Treatment of Fatigue in Lung Cancer V9.0

Modafinil for the Treatment of Fatigue in Lung Cancer: a Multicentre, Randomised, Double-blinded, Placebo-controlled Trial

Sponsor: University of Oxford

Conditions Carcinoma, Non-Small-Cell Lung

Interventions Modafinil Placebo

Updated 7 times since 2017 Last updated: Aug 16, 2013 Started: Feb 28, 2009 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00829322, this PHASE4 trial focuses on Carcinoma, Non-Small-Cell Lung and remains completed. Sponsored by University of Oxford, it has been updated 7 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oxford

Data source: University of Oxford

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aylesbury, United Kingdom , Cheshire, United Kingdom , County Durham, United Kingdom , Essex, United Kingdom , Hampshire, United Kingdom , Kent, United Kingdom , Kings Lynn, United Kingdom , Llandough, United Kingdom , London, United Kingdom , Manchester, United Kingdom and 10 more locations